Pfizer to offload about 6% stake in Sensodyne-maker Haleon, says bookrunner
Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, reducing the top shareholder's interest in the Sensodyne maker to 16.2%. Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.